References
- Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 2006; 129:15–26.
- Salpeter SR, Buckley NS, Ormiston TM, Salpeter EE. Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths. Ann Intern Med 2006; 144(12):904–912.
- Ayres JG, Fish DR, Wheeler DC, Wiggins J, Cochrane GM, Skinner C. Subcutaneous terbutaline and control of brittle asthma or appreciable morning dipping. BMJ 1984; 288:1715–1716.
- Scottish Intercollegiate Guidelines Network and British Thoracic Society. British guideline on the management of asthma: a national clinical guideline. Revised 2009. Available at: http://www.sign.ac.uk/pdf/sign101.pdf. Accessed September 8, 2010.
- O’Driscoll BRC, Ruffles SP, Ayres JG, Cochrane GM. Long-term treatment of severe asthma with subcutaneous terbutaline. Br J Dis Chest 1988; 82:360–365.
- Ayres JG. Continuous subcutaneous bronchodilators in brittle asthma. Br J Hosp Med 1992; 47:569–571.
- Sullivan J, Midgley L, Manney S, Mansur AA. Study of long-term efficacy of using continuous and/or intermittent infusions of terbutaline in unstable severe asthma. Thorax 2008; 63(7):A121; Abstract P118.
- Brémont F, Moisan V, Dutau G. Continuous subcutaneous infusion of β2-agonists in infantile asthma. Pediatr Pulmonol 1992; 12(2):81–83.
- Payne DN, Balfour-Lynn IM, Biggart EA, Bush A, Rosenthal M. Subcutaneous terbutaline in children with chronic severe asthma. Pediatr Pulmonol 2002; 33:356–361.
- Spiteri MA, Millar AB, Pavia D, Clarke SW. Subcutaneous adrenaline versus terbutaline in the treatment of acute severe asthma. Thorax 1988; 43:19–23.
- Amory DW, Burnham SC, Cheney Jr, FW. Comparison of the cardiopulmonary effects of subcutaneously administered epinephrine and terbutaline in patients with reversible airway obstruction. Chest 1975; 67(3):279–286.
- Zehner WJ, Scott JM, Iannolo PM, Ungaro A, Terndrup TE. Terbutaline vs albuterol for out-of-hospital respiratory distress: randomized, double-blind trial. Acad Emerg Med 1995; 2(8):686–691.
- Wong LB, Miller IF, Yeates DB. Regulation of ciliary beat frequency by autonomic mechanisms in vitro. J Appl Physiol 1988; 65:1895–1901.
- Sykes AP, Ayres JG. Further bronchodilatation from low dose inhaled beta 2-agonists in patients receiving infused terbutaline. Thorax 1991; 46:319.
- Hancox RJ, Aldridge RE, Cowan JO, Flannery EM, Herbison GP, McLachlan CR, Town GI, Taylor DR. Tolerance to beta agonists during acute bronchoconstriction. Eur Respir J 1999; 14:283–287.
- Clover S, Smith J, Niven RML. Use of parental long-term bronchodilators in the management of severe and life-threatening asthma. Oral presentation at the ERS Congress, Vienna 2003; Abstract 197. Available at: http://www.ers-education.org/pages/default.aspx?id=399andidBrowse=20345anddet=1. Accessed October 18, 2010.
- Larsson K, Martinsson A, Hjemdahl P. Influence of β-adrenergic receptor function during terbutaline treatment on allergen sensitivity and bronchodilator response to terbutaline in asthmatic subjects. Chest 1992; 101:953–960.
- Sykes AP, Higgins AH, Ayres JG. Continuous subcutaneous terbutaline is effective in the treatment of brittle asthma by achieving high serum terbutaline levels. Thorax 1987; 42:231.
- Jarvie DR, Thompson AM, Dyson EH. Laboratory and clinical features of self-poisoning with salbutamol and terbutaline. Clin Chem Acta 1987; 305:485–488.
- Lewis LD, O’Driscoll BRC, Hartley RB, Cochrane GM. An unusual local reaction to continuous subcutaneous infused terbutaline in unstable asthmatics. Br J Dis Chest 1987; 81:189–193.
- Tunnicliffe WS, Duncanson RC, Fletcher TJ, et al. Site problems in type 1 brittle asthmatics using continuous subcutaneous infusions of terbutaline (CSIT). Thorax 1995; 50(2):A74.
- Sykes AP, Lawson N, Finnegan JA, Ayres JG. Creatinine kinase activity in patients with brittle asthma treated with long term subcutaneous terbutaline. Thorax 1991; 46:580–583.
- Snidow J, Stephens M, Self T, Stewart C, Bobo L, Pieper JA. Acute effects of short-term subcutaneous terbutaline on theophylline disposition. Eur J Clin Pharmaol 1987; 32(2):191–193.
- Skorodin MS, Freebeck PC, Yetter B, Nelson JE, Van de Graaff WB, Walsh JM. Magnesium sulfate potentiates several cardiovascular and metabolic actions of terbutaline. Chest 1994; 105(3):701–705.
- Ritholz MD, Smaldone A, Lee J, Castillo A, Wolpert H, Weinger K. Perceptions of psychosocial factors and the insulin pump. Diabetes Care 2007; 30(3):549–554.
- Ayres JG, Miles JF, Barnes PJ. Brittle asthma. Thorax 1998; 53:315–321.